盘中临床试验
Clinical Trials in a Dish.
作者信息
Strauss David G, Blinova Ksenia
机构信息
Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Division of Biomedical Physics, Office of Science of Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA.
出版信息
Trends Pharmacol Sci. 2017 Jan;38(1):4-7. doi: 10.1016/j.tips.2016.10.009. Epub 2016 Nov 19.
Abstract
Clinical trials 'in a dish' involve testing medical therapies for safety or effectiveness in the laboratory with human tissue. This has become possible owing to recent biotechnology advances including induced pluripotent stem cells, organs-on-a-chip, and whole-genome sequencing. We provide here an overview of the landscape and highlight steps the FDA is taking to advance the science of clinical trials in a dish and to support the development and validation of new regulatory paradigms to assess drug safety using these new technologies.
摘要
“盘中”临床试验涉及在实验室中利用人体组织对医学疗法的安全性或有效性进行测试。由于包括诱导多能干细胞、芯片器官和全基因组测序在内的近期生物技术进展，这已成为可能。我们在此概述了这一领域的情况，并重点介绍了美国食品药品监督管理局（FDA）为推动“盘中”临床试验科学发展以及支持开发和验证使用这些新技术评估药物安全性的新监管范式所采取的步骤。
相似文献
1
Clinical Trials in a Dish.盘中临床试验
Trends Pharmacol Sci. 2017 Jan;38(1):4-7. doi: 10.1016/j.tips.2016.10.009. Epub 2016 Nov 19.
2
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.下一代疗法：利用诱导多能干细胞、基因组学、人工智能以及体外临床试验开拓药物研发。
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.
3
Clinical trials in-a-dish for cardiovascular medicine.在心血管医学中进行临床试验。
Eur Heart J. 2024 Oct 21;45(40):4275-4290. doi: 10.1093/eurheartj/ehae519.
4
Challenges in designing and executing clinical trials in a dish studies.在培养皿研究中设计和开展临床试验所面临的挑战。
J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):73-82. doi: 10.1016/j.vascn.2018.09.002. Epub 2018 Sep 26.
5
Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio-Oncology.简明综述：精准匹配：诱导多能干细胞与心血管肿瘤学相遇。
Stem Cells Transl Med. 2019 Aug;8(8):758-767. doi: 10.1002/sctm.18-0279. Epub 2019 Apr 24.
6
Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.再生治疗的希望：迈向基于人类多能干细胞疗法的安全移植。
Regen Med. 2015;10(2):99-102. doi: 10.2217/rme.14.89.
7
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.诱导多能干细胞——疾病建模和药物发现的机会。
Nat Rev Drug Discov. 2011 Nov 11;10(12):915-29. doi: 10.1038/nrd3577.
8
Applications, Limitations, and Considerations of Clinical Trials in a Dish.培养皿中临床试验的应用、局限性及注意事项
Bioengineering (Basel). 2024 Oct 30;11(11):1096. doi: 10.3390/bioengineering11111096.
9
Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.人诱导多能干细胞临床应用的关键预期监管问题。
Regen Med. 2012 Sep;7(5):713-20. doi: 10.2217/rme.12.51. Epub 2012 Jul 26.
10
Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.日本伴随诊断的发展前景及鼓励个性化医疗的监管环境。
Breast Cancer. 2016 Jan;23(1):19-23. doi: 10.1007/s12282-015-0586-y. Epub 2015 Jan 22.
引用本文的文献
1
Investigation of CFTR Function in Human Nasal Epithelial Cells Informs Personalized Medicine.对人类鼻上皮细胞中CFTR功能的研究为个性化医疗提供依据。
Am J Respir Cell Mol Biol. 2024 Nov;71(5):577-588. doi: 10.1165/rcmb.2023-0398OC.
2
OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology.OptoDyCE平板作为一种适用于全光学心脏电生理学的经济实惠的高通量成像仪。
J Mol Cell Cardiol Plus. 2023 Dec;6. doi: 10.1016/j.jmccpl.2023.100054. Epub 2023 Nov 9.
3
OptoDyCE-plate as an affordable high throughput imager for all optical cardiac electrophysiology.OptoDyCE平板作为一种适用于所有光学心脏电生理学的经济高效的高通量成像仪。
bioRxiv. 2023 Aug 31:2023.08.29.555447. doi: 10.1101/2023.08.29.555447.
4
High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping.使用光学映射对成熟的特定腔室人诱导多能干细胞衍生心肌细胞进行高通量纵向电生理学筛选。
iScience. 2023 Jun 15;26(7):107142. doi: 10.1016/j.isci.2023.107142. eCollection 2023 Jul 21.
5
High-throughput optical sensing of peri-cellular oxygen in cardiac cells: system characterization, calibration, and testing.心脏细胞周细胞氧的高通量光学传感：系统表征、校准和测试。
Front Bioeng Biotechnol. 2023 Jun 16;11:1214493. doi: 10.3389/fbioe.2023.1214493. eCollection 2023.
6
High-throughput optical sensing of peri-cellular oxygen in cardiac cells: system characterization, calibration, and testing.心脏细胞周细胞氧的高通量光学传感：系统表征、校准和测试。
bioRxiv. 2023 Apr 28:2023.04.24.538133. doi: 10.1101/2023.04.24.538133.
7
Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models.心脏收缩力调制刺激在传统二维和三维人诱导多能干细胞衍生心肌细胞模型中的急性效应。
Front Physiol. 2022 Nov 10;13:1023563. doi: 10.3389/fphys.2022.1023563. eCollection 2022.
8
Human in vitro neurocardiac coculture (ivNCC) assay development for evaluating cardiac contractility modulation.人离体神经心肌共培养（ivNCC）检测方法的开发，用于评估心脏收缩力调节。
Physiol Rep. 2022 Nov;10(21):e15498. doi: 10.14814/phy2.15498.
9
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.头颈癌的精准医学：基因组学与临床前研究方法
J Pers Med. 2022 May 24;12(6):854. doi: 10.3390/jpm12060854.
10
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.心肌收缩调节对人诱导多能干细胞衍生心肌细胞的急性影响。
Physiol Rep. 2021 Nov;9(21):e15085. doi: 10.14814/phy2.15085.
本文引用的文献
1
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.通过药物再利用筛选鉴定寨卡病毒感染及诱导神经细胞死亡的小分子抑制剂。
Nat Med. 2016 Oct;22(10):1101-1107. doi: 10.1038/nm.4184. Epub 2016 Aug 29.
2
Site-Specific Genome Engineering in Human Pluripotent Stem Cells.人类多能干细胞中的位点特异性基因组工程
Int J Mol Sci. 2016 Jun 24;17(7):1000. doi: 10.3390/ijms17071000.
3
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress.体外全面致心律失常试验（CiPA）计划——进展更新
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:15-20. doi: 10.1016/j.vascn.2016.06.002. Epub 2016 Jun 7.
4
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.人诱导多能干细胞衍生的心肌细胞重现了乳腺癌患者对阿霉素诱导的心脏毒性的易感性。
Nat Med. 2016 May;22(5):547-56. doi: 10.1038/nm.4087. Epub 2016 Apr 18.
5
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.药物诱导的长QT综合征的晚钠电流阻滞：一项前瞻性临床试验的结果。
Clin Pharmacol Ther. 2016 Feb;99(2):214-23. doi: 10.1002/cpt.205. Epub 2015 Nov 28.
6
Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro.人诱导多能干细胞来源的肝细胞样细胞在体外支持疟原虫肝期感染。
Stem Cell Reports. 2015 Mar 10;4(3):348-59. doi: 10.1016/j.stemcr.2015.01.002. Epub 2015 Feb 7.
7
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.使用原代和诱导多能干细胞衍生的肝细胞系统对乙型肝炎病毒与宿主相互作用进行建模。
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8. doi: 10.1073/pnas.1412631111. Epub 2014 Aug 4.
8
Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.同源人诱导多能干细胞的基因组编辑重现药物测试的长 QT 表型。
J Am Coll Cardiol. 2014 Aug 5;64(5):451-9. doi: 10.1016/j.jacc.2014.04.057.
9
Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.人诱导多能干细胞衍生的心肌细胞作为柯萨奇病毒 B3 诱导心肌炎的体外模型和抗病毒药物筛选平台。
Circ Res. 2014 Aug 29;115(6):556-66. doi: 10.1161/CIRCRESAHA.115.303810. Epub 2014 Jul 11.
10
Approaching the in vitro clinical trial: engineering organs on chips.走近体外临床试验：芯片上的工程化器官
Lab Chip. 2014 Sep 7;14(17):3181-6. doi: 10.1039/c4lc00276h.
Zotero 插件